Angus Russell

Mr. Angus C.
Russell is an Independent Director at Structure Therapeutics, Inc. and an Independent Director at Lineage Cell Therapeutics, Inc. He is on the Board of Directors at Structure Therapeutics, Inc. and Lineage Cell Therapeutics, Inc. Mr. Russell was previously employed as an Independent Director by TherapeuticsMD, Inc., a Chairman by Mallinckrodt Plc, a Non-Executive Chairman by Revance Therapeutics, Inc., an Independent Director by InterMune, Inc., a Non-Executive Director by The City of London Investment Trust Plc, a Chief Executive Officer & Director by Shire Plc, a Chief Financial Officer by Shire Plc /Old/, a Vice President-Corporate Finance by AstraZeneca PLC, a Principal by Imperial Chemical Industries Plc, a Treasurer by Zeneca Garden Care, a Non-Executive Director by Investment Trust Ltd., and a Chief Financial Officer & Director by Shire Acquisition, Inc. He also served on the board at Questcor Pharmaceuticals, Inc.